Schlafen family member 5 (SLFN5) regulates LAT1-mediated mTOR activation in castration-resistant prostate cancer
Martinez, R. S.; Salji, M. J.; Rushworth, L.; Ntala, C.; Rodriguez Blanco, G.; Hedley, A.; Clark, W.; Peixoto, P.; Hervouet, E.; Renaude, E.; Kung, S. H.; Galbraith, L. C.; Nixon, C.; Lilla, S.; MacKay, G. M.; Fazli, L.; Sumpton, D.; Gleave, M. E.; Zanivan, S. R.; Blomme, A.; Leung, H. Y.
Show abstract
Androgen-deprivation therapy (ADT) is the standard of care for the treatment of non-resectable prostate cancer (PCa). Despite high treatment efficiency, most patients ultimately develop lethal castration-resistant prostate cancer (CRPC). In this study, we perform a comparative proteomic analysis of three in vivo, androgen receptor (AR)-driven, orthograft models of CRPC. Differential proteomic analysis reveals that distinct molecular mechanisms, including amino acid (AA) and fatty acid (FA) metabolism, are involved in the response to ADT between the different models. Despite this heterogeneity, we identify SLFN5 as an AR-regulated biomarker in CRPC. SLFN5 expression is high in CRPC tumours and correlates with poor patient outcome. In vivo, SLFN5 depletion strongly impairs tumour growth in castrated condition. Mechanistically, SLFN5 interacts with ATF4 and regulates the expression of LAT1, an essential AA transporter. Consequently, SLFN5 depletion in CRPC cells decreases intracellular levels of essential AA and impairs mTORC1 signalling in a LAT1-dependent manner.
Matching journals
The top 8 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Peroxisomal β-oxidation enzyme, DECR2, regulates lipid metabolism and promotes treatment resistance in advanced prostate cancer 98%
- Loss of ARID1A accelerates prostate tumourigenesis with a proliferative collagen-poor phenotype through co-operation with AP1 subunit cFos 95%
- Bypassing cisplatin resistance in Nrf2 hyperactivated head and neck cancer through effective PI3Kinase targeting 94%
Similar papers in this journal
- Role of Specialized mSWI/SNF Complexes in Prostate Cancer Lineage Plasticity 97%
- C/EBPB-dependent Adaptation to Palmitic Acid Promotes Stemness in Hormone Receptor Negative Breast Cancer 95%
- Chronic circadian disruption modulates breast cancer cell stemness and their immune microenvironment to drive metastasis in mice 95%
Similar papers in this journal
- Disassembly of hemidesmosomes promotes tumorigenesis in PTEN-negative prostate cancer by targeting plectin into focal adhesions 96%
- AR coactivators, CBP/p300, are critical mediators of DNA repair in prostate cancer 95%
- A novel role for Neurog2 in MYCN driven neuroendocrine plasticity of prostate cancer 95%
Similar papers in this journal
- Stroma transcriptomic and proteomic profile of prostate cancer metastasis xenograft models reveals conservation of bonemicroenvironment signatures 95%
- Early neutrophilia marked by aerobic glycolysis sustains host metabolism and delays cancer cachexia 94%
- Propagated circulating tumor cells uncovers the rople of NFκB and COP1 in metastasis 93%
Similar papers in this journal
- Unraveling the YAP1-TGFβ1 axis: a key driver of androgen receptor loss in prostate cancer-associated fibroblasts 96%
- Blood-based detection of MMP11 as a marker of prostate cancer progression regulated by the ALDH1A1-TGF-β1 signaling mechanism 95%
- Long-term patient-derived ovarian cancer organoids closely recapitulate tumor of origin and clinical response 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.